Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
NCT ID:
NCT01642251
Group ID:
EG003
Title:
Phase II: Arm E (Placebo)
Description:
Patients receive placebo PO BID on days 1-7, etoposide IV over 60-120 minutes on days 1-3, and cisplatin IV over 60-120 minutes on day 1. Treatment repeats every 21 days for 4 courses in the absence of disease progression or unacceptable toxicity.
Cisplatin: Given IV Etoposide: Given IV Placebo: placebo of Veliparib
Deaths Number Affected:
54
Deaths Number At Risk:
None
Serious Number Affected:
40
Serious Number At Risk:
66
Other Number Affected:
62
Other Number At Risk:
66
Study:
NCT01642251
Results Section:
NCT01642251
Adverse Events Module:
NCT01642251